Portal:COVID-19

The COVID-19 portal

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the virus SARS-CoV-2. The first known case was identified in Wuhan, China, in December 2019. The disease quickly spread worldwide, resulting in the COVID-19 pandemic.

Transmission and life-cycle of SARS-CoV-2 causing COVID-19.

Several COVID-19 vaccines have been approved and distributed in various countries, which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While work is underway to develop drugs that inhibit the virus, the primary treatment is symptomatic. Management involves the treatment of symptoms through supportive care, isolation, and experimental measures.

The pandemic caused severe social and economic disruption around the world, including the largest global recession since the Great Depression. Widespread supply shortages, including food shortages, were caused by supply chain disruptions and panic buying. Reduced human activity led to an unprecedented decrease in pollution. Educational institutions and public areas were partially or fully closed in many jurisdictions, and events were cancelled or postponed during 2020 and 2021. Many white-collar workers began working from home. Misinformation circulated through social media and mass media, and political tensions intensified. The pandemic raised issues of racial and geographic discrimination, health equity, and the balance between public health imperatives and individual rights. (Full article)

About the virus

SARS-CoV-2 as seen by a cryo-electron tomography scan.

SARS‑CoV‑2 belongs to the broad family of viruses known as coronaviruses. It is a positive-sense single-stranded RNA (+ssRNA) virus, with a single linear RNA segment. Coronaviruses infect humans, other mammals, including livestock and companion animals, and avian species. Human coronaviruses are capable of causing illnesses ranging from the common cold to more severe diseases such as Middle East respiratory syndrome (MERS, fatality rate ~34%). SARS-CoV-2 is the seventh known coronavirus to infect people, after 229E, NL63, OC43, HKU1, MERS-CoV, and the original SARS-CoV.

Like the SARS-related coronavirus implicated in the 2003 SARS outbreak, SARS‑CoV‑2 is a member of the subgenus Sarbecovirus (beta-CoV lineage B). Coronaviruses undergo frequent recombination. The mechanism of recombination in unsegmented RNA viruses such as SARS-CoV-2 is generally by copy-choice replication, in which gene material switches from one RNA template molecule to another during replication. The SARS-CoV-2 RNA sequence is approximately 30,000 bases in length, relatively long for a coronavirus—which in turn carry the largest genomes among all RNA families. Its genome consists nearly entirely of protein-coding sequences, a trait shared with other coronaviruses. (Full article)

Disease progress

As of 28 October 2023, 771,548,954 cases of COVID-19 have been reported, resulting in 6,974,460 reported deaths.[1]


Updated October 28, 2023.
COVID-19 pandemic by location[1]
Location Cases Deaths
World[lower-alpha 1] 771,548,954 6,974,460
European Union European Union[lower-alpha 2] 184,262,967 1,245,804
United States United States 103,436,829 1,136,920
China China[lower-alpha 3] 99,316,932 121,764
India India 45,001,052 533,291
France France 38,997,490 167,985
Germany Germany 38,437,756 174,979
Brazil Brazil 37,721,749 704,659
South Korea South Korea 34,571,873 35,934
Japan Japan 33,803,572 74,694
Italy Italy 26,202,253 192,210
United Kingdom United Kingdom 24,789,488 230,669
Russia Russia 23,098,734 400,195
Turkey Turkey 17,004,677 101,419
Spain Spain 13,980,340 121,852
Vietnam Vietnam 11,624,000 43,206
Australia Australia 11,623,332 23,289
Argentina Argentina 10,054,576 130,472
Taiwan Taiwan 9,970,937 17,672
Netherlands Netherlands 8,618,815 22,986
Mexico Mexico 7,692,603 334,727
Iran Iran 7,619,981 146,480
Indonesia Indonesia 6,813,429 161,918
Poland Poland 6,527,077 119,657
Colombia Colombia 6,382,720 142,942
Austria Austria 6,081,287 22,534
Portugal Portugal 5,621,015 27,424
Ukraine Ukraine 5,520,483 109,918
Greece Greece 5,405,742 37,572
Chile Chile 5,288,869 61,609
Malaysia Malaysia 5,131,899 37,200
Israel Israel 4,840,714 12,697
Belgium Belgium 4,817,196 34,339
Thailand Thailand 4,757,919 34,485
Canada Canada 4,716,205 53,297
Czech Republic Czech Republic 4,661,103 42,900
Peru Peru 4,520,727 221,704
Switzerland Switzerland 4,417,131 14,073
Philippines Philippines 4,117,183 66,714
South Africa South Africa 4,072,533 102,595
Romania Romania 3,485,792 68,455
Denmark Denmark 3,417,017 8,824
Hong Kong Hong Kong 2,876,106 13,466
Sweden Sweden 2,719,400 24,950
Singapore Singapore 2,641,196 1,872
Serbia Serbia 2,563,994 18,057
Iraq Iraq 2,465,545 25,375
New Zealand New Zealand 2,393,977 3,393
Hungary Hungary 2,207,993 48,817
Bangladesh Bangladesh 2,045,892 29,477
Slovakia Slovakia 1,867,933 21,167
Georgia (country) Georgia 1,855,289 17,132
Jordan Jordan 1,746,997 14,122
Republic of Ireland Republic of Ireland 1,723,096 9,262
Pakistan Pakistan 1,580,631 30,656
Kazakhstan Kazakhstan 1,502,857 19,072
Norway Norway 1,489,459 5,732
Finland Finland 1,488,381 10,371
Slovenia Slovenia 1,345,384 9,448
Lithuania Lithuania 1,335,551 9,729
Bulgaria Bulgaria 1,302,188 38,414
Morocco Morocco 1,277,082 16,297
Croatia Croatia 1,276,001 18,397
Guatemala Guatemala 1,271,073 20,236
Puerto Rico Puerto Rico 1,252,713 5,938
Lebanon Lebanon 1,239,904 10,947
Costa Rica Costa Rica 1,238,884 9,428
Bolivia Bolivia 1,209,431 22,404
Tunisia Tunisia 1,153,361 29,423
Cuba Cuba 1,115,103 8,530
Ecuador Ecuador 1,069,139 36,043
United Arab Emirates United Arab Emirates 1,067,030 2,349
Panama Panama 1,047,587 8,654
Uruguay Uruguay 1,040,506 7,635
Mongolia Mongolia 1,011,170 2,284
Nepal Nepal 1,003,450 12,031
Belarus Belarus 994,037 7,118
Latvia Latvia 976,316 7,384
Saudi Arabia Saudi Arabia 841,469 9,646
Azerbaijan Azerbaijan 833,955 10,353
Paraguay Paraguay 735,921 19,981
State of Palestine Palestine 703,228 5,708
Bahrain Bahrain 696,614 1,536
Sri Lanka Sri Lanka 672,597 16,882
Dominican Republic Dominican Republic 667,074 4,384
Kuwait Kuwait 666,432 2,570
Cyprus Cyprus 660,854 1,364
Myanmar Myanmar 641,335 19,494
Moldova Moldova 625,712 12,135
Estonia Estonia 602,187 2,902
Venezuela Venezuela 552,695 5,856
Egypt Egypt 516,023 24,830
Qatar Qatar 514,524 690
Libya Libya 507,269 6,437
Ethiopia Ethiopia 501,060 7,574
Réunion Réunion 494,595 921
Honduras Honduras 474,587 11,127
Armenia Armenia 450,334 8,762
Bosnia and Herzegovina Bosnia and Herzegovina 403,266 16,362
Oman Oman 399,449 4,628
Luxembourg Luxembourg 384,378 1,000
Zambia Zambia 349,287 4,069
North Macedonia North Macedonia 349,104 9,946
Kenya Kenya 344,070 5,689
Albania Albania 334,090 3,604
Botswana Botswana 330,321 2,800
Brunei Brunei 312,094 163
Mauritius Mauritius 309,983 1,054
Kosovo Kosovo 274,279 3,212
Algeria Algeria 271,945 6,881
Nigeria Nigeria 267,146 3,155
Zimbabwe Zimbabwe 265,821 5,720
Montenegro Montenegro 251,280 2,654
Mozambique Mozambique 233,654 2,249
Martinique Martinique 230,354 1,104
Afghanistan Afghanistan 226,843 7,952
Laos Laos 218,885 671
Iceland Iceland 209,142 186
Guadeloupe Guadeloupe 203,235 1,021
El Salvador El Salvador 201,808 4,230
Trinidad and Tobago Trinidad and Tobago 191,496 4,390
Maldives Maldives 186,694 316
Uzbekistan Uzbekistan 174,123 1,016
Namibia Namibia 172,123 4,100
Uganda Uganda 171,871 3,632
Ghana Ghana 171,653 1,462
Jamaica Jamaica 156,433 3,611
Cambodia Cambodia 138,941 3,056
Rwanda Rwanda 133,194 1,468
Cameroon Cameroon 125,090 1,974
Malta Malta 120,422 882
Barbados Barbados 110,082 620
Angola Angola 105,976 1,936
Democratic Republic of the Congo Democratic Republic of the Congo 99,181 1,468
French Guiana French Guiana 98,041 413
Senegal Senegal 89,022 1,971
Malawi Malawi 88,986 2,686
Kyrgyzstan Kyrgyzstan 88,889 1,024
Ivory Coast Ivory Coast 88,338 835
Suriname Suriname 82,588 1,408
New Caledonia New Caledonia 80,064 314
French Polynesia French Polynesia 78,649 649
Eswatini Eswatini 75,094 1,427
Guyana Guyana 73,388 1,299
Belize Belize 71,060 688
Fiji Fiji 69,047 885
Madagascar Madagascar 68,354 1,425
Jersey Jersey 66,391 161
Cape Verde Cabo Verde 64,470 416
Sudan Sudan 63,993 5,046
Mauritania Mauritania 63,774 997
Bhutan Bhutan 62,697 21
Syria Syria 57,423 3,163
Burundi Burundi 54,366 15
Guam Guam 52,050 417
Seychelles Seychelles 50,937 172
Gabon Gabon 48,992 307
Andorra Andorra 48,015 159
Papua New Guinea Papua New Guinea 46,864 670
Curaçao Curaçao 45,883 305
Aruba Aruba 44,224 292
Tanzania Tanzania 43,078 846
Mayotte Mayotte 42,027 187
Togo Togo 39,524 290
Guinea Guinea 38,563 468
The Bahamas Bahamas 38,084 844
Isle of Man Isle of Man 38,008 116
Lesotho Lesotho 35,836 709
Guernsey Guernsey 35,326 67
Faroe Islands Faroe Islands 34,658 28
Haiti Haiti 34,403 860
Mali Mali 33,159 743
Cayman Islands Cayman Islands 31,472 37
Saint Lucia Saint Lucia 30,149 410
Benin Benin 28,036 163
Somalia Somalia 27,334 1,361
Federated States of Micronesia Federated States of Micronesia 26,547 65
Solomon Islands Solomon Islands 25,954 199
United States Virgin Islands United States Virgin Islands 25,389 132
Republic of the Congo Republic of the Congo 25,196 389
San Marino San Marino 24,697 126
East Timor Timor-Leste 23,460 138
Burkina Faso Burkina Faso 22,056 396
Liechtenstein Liechtenstein 21,504 87
Gibraltar Gibraltar 20,550 113
Grenada Grenada 19,693 238
Bermuda Bermuda 18,860 165
South Sudan South Sudan 18,368 138
Tajikistan Tajikistan 17,786 125
Equatorial Guinea Equatorial Guinea 17,130 183
Monaco Monaco 17,072 67
Tonga Tonga 16,846 12
Samoa Samoa 16,778 31
Marshall Islands Marshall Islands 16,138 17
Nicaragua Nicaragua 16,053 245
Dominica Dominica 15,798 74
Djibouti Djibouti 15,690 189
Central African Republic Central African Republic 15,367 113
Northern Mariana Islands Northern Mariana Islands 14,306 41
The Gambia Gambia 12,626 372
Collectivity of Saint Martin Collectivity of Saint Martin 12,324 46
Vanuatu Vanuatu 12,019 14
Greenland Greenland 11,971 21
Yemen Yemen 11,945 2,159
Caribbean Netherlands Caribbean Netherlands 11,922 41
Sint Maarten Sint Maarten 11,051 92
Eritrea Eritrea 10,189 103
Saint Vincent and the Grenadines Saint Vincent and the Grenadines 9,644 124
Guinea-Bissau Guinea-Bissau 9,614 177
Niger Niger 9,515 315
Comoros Comoros 9,109 160
Antigua and Barbuda Antigua and Barbuda 9,106 146
American Samoa American Samoa 8,359 34
Liberia Liberia 7,930 294
Sierra Leone Sierra Leone 7,766 125
Chad Chad 7,698 194
British Virgin Islands British Virgin Islands 7,305 64
Cook Islands Cook Islands 7,168 2
Turks and Caicos Islands Turks and Caicos Islands 6,630 39
Saint Kitts and Nevis Saint Kitts and Nevis 6,607 46
São Tomé and Príncipe Sao Tome and Principe 6,601 80
Palau Palau 6,243 9
Saint Barthélemy Saint Barthélemy 5,507 5
Nauru Nauru 5,393 1
Kiribati Kiribati 5,085 24
Anguilla Anguilla 3,904 12
Wallis and Futuna Wallis and Futuna 3,550 8
Macau Macau 3,514 121
Saint Pierre and Miquelon Saint Pierre and Miquelon 3,426 2
Tuvalu Tuvalu 2,943 1
Saint Helena, Ascension and Tristan da Cunha Saint Helena, Ascension and Tristan da Cunha 2,166
Falkland Islands Falkland Islands 1,923
Montserrat Montserrat 1,403 8
Niue Niue 887
Tokelau Tokelau 80 0
Vatican City Vatican City 26 0
Pitcairn Islands Pitcairn Islands 4
North Korea North Korea 1 6
Turkmenistan Turkmenistan 0 0
  1. Countries which do not report data for a column are not included in that column's world total.
  2. Data on member states of the European Union are individually listed, but are also summed here for convenience. They are not double-counted in world totals.
  3. Does not include special administrative regions (Hong Kong and Macau) or Taiwan.

About the symptoms

Symptoms of coronavirus disease 2019 (COVID-19)

The symptoms of COVID-19 are variable depending on the type of variant contracted, ranging from mild symptoms to a potentially fatal illness. Common symptoms include coughing, fever, loss of smell (anosmia) and taste (ageusia), with less common ones including headaches, nasal congestion and runny nose, muscle pain, sore throat, diarrhea, eye irritation, and toes swelling or turning purple, and in moderate to severe cases, breathing difficulties. People with the COVID-19 infection may have different symptoms, and their symptoms may change over time. Three common clusters of symptoms have been identified: one respiratory symptom cluster with cough, sputum, shortness of breath, and fever; a musculoskeletal symptom cluster with muscle and joint pain, headache, and fatigue; and a cluster of digestive symptoms with abdominal pain, vomiting, and diarrhea. In people without prior ear, nose, or throat disorders, loss of taste combined with loss of smell is associated with COVID-19 and is reported in as many as 88% of symptomatic cases. (Full article)

About the spread

COVID-19 is mainly transmitted when people breathe in air contaminated by droplets/aerosols and small airborne particles containing the virus. Infected people exhale those particles as they breathe, talk, cough, sneeze, or sing. Transmission is more likely the closer people are. However, infection can occur over longer distances, particularly indoors.

Infectious particles range in size from aerosols that remain suspended in the air for long periods of time to larger droplets that remain airborne briefly or fall to the ground. Additionally, COVID-19 research has redefined the traditional understanding of how respiratory viruses are transmitted. The largest droplets of respiratory fluid do not travel far, but can be inhaled or land on mucous membranes on the eyes, nose, or mouth to infect. Aerosols are highest in concentration when people are in close proximity, which leads to easier viral transmission when people are physically close, but airborne transmission can occur at longer distances, mainly in locations that are poorly ventilated; in those conditions small particles can remain suspended in the air for minutes to hours. (Full article)

Containment measures

Goals of mitigation include delaying and reducing peak burden on healthcare (flattening the curve) and lessening overall cases and health impact.
Many countries attempted to slow or stop the spread of COVID-19 by recommending, mandating or prohibiting behaviour changes, while others relied primarily on providing information. Measures ranged from public advisories to stringent lockdowns. Outbreak control strategies are divided into elimination and mitigation. Experts differentiate between" zero-COVID", which is an elimination strategy, and mitigation strategies that attempt to lessen the effects of the virus on society, but which still tolerate some level of transmission within the community. Containment strategies consists of the use of public health measures such as contact tracing, mass testing, border quarantine, lockdowns and mitigation software.These strategies can be pursued sequentially or simultaneously during the acquired immunity phase through natural and vaccine-induced immunity.

Videos

Recent news

12 October 2023 –
International Monetary Fund managing director Kristalina Georgieva confirms that Zambia, the first African nation to default following the COVID-19 pandemic, has agreed to a debt agreement with foreign creditors concerning US$6.3 billion of its debt. (AFP via Business Recorder)
2 October 2023 –
Katalin Karikó and Drew Weissman are awarded the Nobel Prize in Physiology or Medicine for developing technology that resulted in mRNA vaccines for COVID-19. (BBC News)
27 August 2023 – COVID-19 pandemic
COVID-19 pandemic in North Korea
The North Korean government announces the lifting of certain pandemic-era travel restrictions, allowing citizens abroad to return to the country provided that they quarantine for one week. (AFP via WION)
23 August 2023 – COVID-19 pandemic in the United States
The U.S. Justice Department announces that they have brought 718 law enforcement actions costing $836 million in COVID-19 fraud during the pandemic. (The Washington Post)

Did you know?

Data maps

Economic impact

The COVID-19 pandemic has had far-reaching economic consequences including the COVID-19 recession, the second largest global recession in recent history, decreased business in the services sector during the COVID-19 lockdowns, the 2020 stock market crash, which included the largest single-week stock market decline since the financial crisis of 2007–2008 and the impact of COVID-19 on financial markets, the 2021–2022 global supply chain crisis, the 2021–2022 inflation surge, shortages related to the COVID-19 pandemic including the 2020–present global chip shortage, panic buying, and price gouging. It led to governments providing an unprecedented amount of stimulus. The pandemic was also a factor in the 2021–2022 global energy crisis and 2022 food crises.

Many fashion, sport, and technology events have been canceled or have changed to be online. While the monetary impact on the travel and trade industry is yet to be estimated, it is likely to be in the billions and increasing. (Full article)

Workplace

Hazard controls for COVID-19 in workplaces are the application of occupational safety and health methodologies for hazard controls to the prevention of COVID-19. Vaccination is the most effective way to protect against severe illness or death from COVID-19. Multiple layers of controls are recommended, including measures such as remote work and flextime, increased ventilation, personal protective equipment (PPE) and face coverings, social distancing, and enhanced cleaning programs. (Full article)

Misinformation

False information, including intentional disinformation and conspiracy theories, about the scale of the COVID-19 pandemic and the origin, prevention, diagnosis, and treatment of the disease has been spread through social media, text messaging, and mass media. False information has been propagated by celebrities, politicians, and other prominent public figures. Many countries have passed laws against "fake news", and thousands of people have been arrested for spreading COVID-19 misinformation. The spread of COVID-19 misinformation by governments has also been significant. (Full article)

Testing

COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main types of tests detect either the presence of the virus or antibodies produced in response to infection. Molecular tests for viral presence through its molecular components are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests (serology immunoassays) instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection. It is used to assess disease prevalence, which aids the estimation of the infection fatality rate. (Full article)

Vaccine research

A COVID19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID19).

The COVID19 vaccines are widely credited for their role in reducing the spread of COVID19 and reducing the severity and death caused by COVID19. According to a June 2022 study, COVID19 vaccines prevented an additional 14.4 to 19.8 million deaths in 185 countries and territories from 8 December 2020 to 8 December 2021. Many countries implemented phased distribution plans that prioritized those at highest risk of complications, such as the elderly, and those at high risk of exposure and transmission, such as healthcare workers. (Full article)

Drug research

COVID-19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus disease 2019 (COVID-19). From early 2020 through 2021, several hundred drug companies, biotechnology firms, university research groups, and health organizations were developing therapeutic candidates for COVID-19 disease in various stages of preclinical or clinical research (506 total candidates in April 2021), with 419 potential COVID-19 drugs in clinical trials, as of April 2021. (Full article)

Images

Topics

Get involved!

Get involved by joining WikiProject COVID-19. We discuss collaborations and all manner of issues on our talk page. As of 28 October 2023, there are 2,413 articles within the project's scope. A full list is available here.

Categories

Category puzzle
Category puzzle

Select [►] to view subcategories

COVID-19
COVID-19 pandemic templates

References

  1. Ritchie, Hannah; Mathieu, Edouard; Rodés-Guirao, Lucas; Appel, Cameron; Giattino, Charlie; Ortiz-Ospina, Esteban; Hasell, Joe; Macdonald, Bobbie; Beltekian, Diana; Dattani, Saloni; Roser, Max (2020–2022). "Coronavirus Pandemic (COVID-19)". Our World in Data. Retrieved 2023-10-28.

    Associated Wikimedia

    The following Wikimedia Foundation sister projects provide more on this subject:

    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.